peruvoside (Q7171218)

14-Hydroxy-19-oxo-5beta-card-20(22)-enolid-3beta-yl 3-O-methyl-6-deoxy-alpha-L-mannopyranoside

peruvoside (English)

14 October 2016

2 references

based on heuristic

inferred from InChIKey

based on heuristic

inferred from InChI

(3S,5R,8R,9S,10R,13R,14S,17R)-3-((2S,3R,4S,5R,6R)-3,5-dihydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yloxy)-14-hydroxy-13-methyl-17-(5-oxo-2,5-dihydrofuran-3-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde

1 reference

based on heuristic

inferred from InChI

chemical formula

C₃₀H₄₄O₉

1 reference

peruvoside (English)

14 October 2016

CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C=O)O)OC)O

1 reference

peruvoside (English)

14 October 2016

C[C@H]1[C@@H]([C@H]([C@@H]([C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)C=O)O)OC)O

1 reference

Glycosides of 19-formylthevetiogenin and 5 alpha-thevetiogenin from Thevetia neriifolia

peruvoside (English)

14 October 2016

3 references

Cardenolides and triterpenoids of the leaves of Thevetia neriifolia

Cardenolide glycosides of Thevetia peruviana and triterpenoid saponins of Sapindus emarginatus as TRAIL resistance-overcoming compounds

subject has role

cardiotonic

1 reference

Medical Subject Headings

MeSH descriptor ID

C100098

InChI=1S/C30H44O9/c1-16-24(33)26(36-3)25(34)27(38-16)39-19-6-10-29(15-31)18(13-19)4-5-22-21(29)7-9-28(2)20(8-11-30(22,28)35)17-12-23(32)37-14-17/h12,15-16,18-22,24-27,33-35H,4-11,13-14H2,1-3H3/t16-,18+,19-,20+,21-,22+,24-,25-,26+,27-,28+,29+,30-/m0/s1

15 March 2018

Identifiers

InChI

1 reference

peruvoside (English)

14 October 2016

2 references

peruvoside (English)

14 October 2016

ChEBI release 2020-09-01

CAS Registry Number

1182-87-2

2 references

Global Substance Registration System

peruvoside (English)

14 October 2016

https://commonchemistry.cas.org/detail?cas_rn=1182-87-2

9 April 2021

1 reference

PERUVOSIDE (English)

14 October 2016

2 references

English

peruvoside (English)

14 October 2016

ChEBI ID

135825

mapping relation type

exact match

2 references

ChEBI release 2019-10-02

International Chemical Identifier

InChI

InChI=1S/C30H44O9/c1-16-24(33)26(36-3)25(34)27(38-16)39-19-6-10-29(15-31)18(13-19)4-5-22-21(29)7-9-28(2)20(8-11-30(22,28)35)17-12-23(32)37-14-17/h12,15-16,18-22,24-27,33-35H,4-11,13-14H2,1-3H3/t16-,18+,19-,20+,21-,22+,24-,25-,26+,27-,28+,29+,30-/m0/s1

1 reference

PERUVOSIDE (English)

14 October 2016

2 references

inferred from InChIKey

1 reference

1 reference

DSSTOX compound identifier

DTXCID501022650

0 references

EC number

214-659-9

1 reference

Global Substance Registration System

English

peruvoside (English)

ECHA Substance Infocard ID

14 October 2016

100.013.327

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.013.327

27 December 2018

(3β,5β)-3-[(6-deoxy-3-O-methyl-α-L-glucopyranosyl)oxy]-14-hydroxy-19-oxocard-20(22)-enolide (English)

quotation

CAS no.: 1182-87-2 (English)

0 references

1 reference

Medical Subject Headings

14 March 2018

1 reference

2 references

Global Substance Registration System

English

peruvoside (English)

14 October 2016